AKBA
$3.31
Akebia Therapeutics
($.02)
(.60%)

Analysts Summary for Akebia Therapeutics

Analysts' Net Recommendation

The net recommendation of analysts covering Akebia Therapeutics

Analysts' Net Recommendation History

An historical view of the net recommendation of analysts covering Akebia Therapeutics

Average Analysts' Target

Analysts' Target History

An historical view of analysts' average target prices for Akebia Therapeutics